Literature DB >> 20952507

p53 status in stromal fibroblasts modulates tumor growth in an SDF1-dependent manner.

Yoseph Addadi1, Neta Moskovits, Dorit Granot, Guillermina Lozano, Yaron Carmi, Ron N Apte, Michal Neeman, Moshe Oren.   

Abstract

The p53 tumor suppressor exerts a variety of cell-autonomous effects that are aimed to thwart tumor development. In addition, however, there is growing evidence for cell nonautonomous tumor suppressor effects of p53. In the present study, we investigated the impact of stromal p53 on tumor growth. Specifically, we found that ablation of p53 in fibroblasts enabled them to promote more efficiently the growth of tumors initiated by PC3 prostate cancer-derived cells. This stimulatory effect was dependent on the increased expression of the chemokine SDF-1 in the p53-deficient fibroblasts. Notably, fibroblasts harboring mutant p53 protein were more effective than p53-null fibroblasts in promoting tumor growth. The presence of either p53-null or p53-mutant fibroblasts led also to a markedly elevated rate of metastatic spread of the PC3 tumors. These findings implicate p53 in a cell nonautonomous tumor suppressor role within stromal fibroblasts, through suppressing the production of tumor stimulatory factors by these cells. Moreover, expression of mutant p53 by tumor stroma fibroblasts might exert a gain of function effect, further accelerating tumor development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20952507      PMCID: PMC2999653          DOI: 10.1158/0008-5472.CAN-10-1146

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

1.  The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis.

Authors:  Gong Yang; Daniel G Rosen; Zhihong Zhang; Robert C Bast; Gordon B Mills; Justin A Colacino; Imelda Mercado-Uribe; Jinsong Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-23       Impact factor: 11.205

Review 2.  Know thy neighbor: stromal cells can contribute oncogenic signals.

Authors:  T D Tlsty; P W Hein
Journal:  Curr Opin Genet Dev       Date:  2001-02       Impact factor: 5.578

3.  Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma.

Authors:  S Pal; K Datta; D Mukhopadhyay
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

4.  Modeling the therapeutic efficacy of p53 restoration in tumors.

Authors:  Carla P Martins; Lamorna Brown-Swigart; Gerard I Evan
Journal:  Cell       Date:  2006-12-21       Impact factor: 41.582

Review 5.  Mutant p53 gain-of-function in cancer.

Authors:  Moshe Oren; Varda Rotter
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

6.  Syndecan-1 expression by stromal fibroblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis.

Authors:  T Maeda; J Desouky; A Friedl
Journal:  Oncogene       Date:  2006-03-02       Impact factor: 9.867

7.  p53 Attenuates cancer cell migration and invasion through repression of SDF-1/CXCL12 expression in stromal fibroblasts.

Authors:  Neta Moskovits; Alexander Kalinkovich; Jair Bar; Tsvee Lapidot; Moshe Oren
Journal:  Cancer Res       Date:  2006-11-15       Impact factor: 12.701

8.  Stroma-derived matrix metalloproteinase (MMP)-2 promotes membrane type 1-MMP-dependent tumor growth in mice.

Authors:  Kaori Taniwaki; Hiroshi Fukamachi; Kiyoshi Komori; Yohei Ohtake; Takahiro Nonaka; Takeharu Sakamoto; Takayuki Shiomi; Yasunori Okada; Takeshi Itoh; Shigeyoshi Itohara; Motoharu Seiki; Ikuo Yana
Journal:  Cancer Res       Date:  2007-05-01       Impact factor: 12.701

Review 9.  Involvement of stromal p53 in tumor-stroma interactions.

Authors:  Jair Bar; Neta Moskovits; Moshe Oren
Journal:  Semin Cell Dev Biol       Date:  2009-11-13       Impact factor: 7.727

10.  CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer.

Authors:  Dingzhi Wang; Haibin Wang; Joanne Brown; Takiko Daikoku; Wei Ning; Qiong Shi; Ann Richmond; Robert Strieter; Sudhansu K Dey; Raymond N DuBois
Journal:  J Exp Med       Date:  2006-03-27       Impact factor: 14.307

View more
  56 in total

Review 1.  Targeted therapies for adrenocortical carcinoma: IGF and beyond.

Authors:  Michael J Demeure; Kimberly J Bussey; Lawrence S Kirschner
Journal:  Horm Cancer       Date:  2011-12       Impact factor: 3.869

2.  Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state.

Authors:  Masayuki Shimoda; Simona Principe; Hartland W Jackson; Valbona Luga; Hui Fang; Sam D Molyneux; Yang W Shao; Alison Aiken; Paul D Waterhouse; Christina Karamboulas; Franz M Hess; Takashi Ohtsuka; Yasunori Okada; Laurie Ailles; Andreas Ludwig; Jeffrey L Wrana; Thomas Kislinger; Rama Khokha
Journal:  Nat Cell Biol       Date:  2014-08-24       Impact factor: 28.824

3.  Interplay between p53 and VEGF: how to prevent the guardian from becoming a villain.

Authors:  S Haupt; C Gamell; K Wolyniec; Y Haupt
Journal:  Cell Death Differ       Date:  2013-07       Impact factor: 15.828

Review 4.  The evolving relationship of wound healing and tumor stroma.

Authors:  Deshka S Foster; R Ellen Jones; Ryan C Ransom; Michael T Longaker; Jeffrey A Norton
Journal:  JCI Insight       Date:  2018-09-20

5.  The role of stromal myofibroblast and extracellular matrix in tumor angiogenesis.

Authors:  Sylvia Vong; Raghu Kalluri
Journal:  Genes Cancer       Date:  2011-12

6.  Cells Comprising the Prostate Cancer Microenvironment Lack Recurrent Clonal Somatic Genomic Aberrations.

Authors:  Daniella Bianchi-Frias; Ryan Basom; Jeffrey J Delrow; Ilsa M Coleman; Olga Dakhova; Xiaoyu Qu; Min Fang; Omar E Franco; Nolan G Ericson; Jason H Bielas; Simon W Hayward; Lawrence True; Colm Morrissey; Lisha Brown; Neil A Bhowmick; David Rowley; Michael Ittmann; Peter S Nelson
Journal:  Mol Cancer Res       Date:  2016-01-11       Impact factor: 5.852

7.  c-Ski activates cancer-associated fibroblasts to regulate breast cancer cell invasion.

Authors:  Liyang Wang; Yixuan Hou; Yan Sun; Liuyang Zhao; Xi Tang; Ping Hu; Jiajia Yang; Zongyue Zeng; Guanglun Yang; Xiaojiang Cui; Manran Liu
Journal:  Mol Oncol       Date:  2013-08-27       Impact factor: 6.603

8.  Priming cancer cells for drug resistance: role of the fibroblast niche.

Authors:  Wei Bin Fang; Min Yao; Nikki Cheng
Journal:  Front Biol (Beijing)       Date:  2014-02-01

9.  Discovery of Stromal Regulatory Networks that Suppress Ras-Sensitized Epithelial Cell Proliferation.

Authors:  Huayang Liu; James A Dowdle; Safiya Khurshid; Nicholas J Sullivan; Nicholas Bertos; Komal Rambani; Markus Mair; Piotr Daniel; Esther Wheeler; Xing Tang; Kyle Toth; Michael Lause; Markus E Harrigan; Karl Eiring; Connor Sullivan; Matthew J Sullivan; Serena W Chang; Siddhant Srivastava; Joseph S Conway; Raleigh Kladney; Joseph McElroy; Sooin Bae; Yuanzhi Lu; Ali Tofigh; Sadiq M I Saleh; Soledad A Fernandez; Jeffrey D Parvin; Vincenzo Coppola; Erin R Macrae; Sarmila Majumder; Charles L Shapiro; Lisa D Yee; Bhuvaneswari Ramaswamy; Michael Hallett; Michael C Ostrowski; Morag Park; Helen M Chamberlin; Gustavo Leone
Journal:  Dev Cell       Date:  2017-05-22       Impact factor: 12.270

10.  Selection of p53-Deficient Stromal Cells in the Tumor Microenvironment.

Authors:  Elena Farmaki; Ioulia Chatzistamou; Panagiotis Bourlis; Eleni Santoukou; George Trimis; Athanasios G Papavassiliou; Hippokratis Kiaris
Journal:  Genes Cancer       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.